Skip to main content

Table 3 Medical utilization in 2 months at 1-year follow-up among the elderly with different baseline frailty status and change of frailty status

From: Frailty status changes are associated with healthcare utilization and subsequent mortality in the elderly population

 

Total n

Number of outpatient visit

Hospitalization admission

Emergency room utilization

Total visits

Non-rehabilitation

Rehabilitation

Geometric mean ± SD

Geometric mean ± SD

Geometric mean ± SD

n (%)

n (%)

Baseline frailty status*

 Frail

37

1.1 ± 7.6 a

0.9 ± 6.5 a

0.0 ± 8.6

1 (2.7%)

1 (2.7%)

 Pre-frail

232

0.6 ± 8.4a

0.6 ± 8.3 a

0.0 ± 2.2

5 (2.2%)

1 (0.4%)

 Robust

279

0.4 ± 9.4

0.4 ± 9.3

0.0 ± 2.1

0 (0.0%)

3 (1.1%)

 p-value+

 

< 0.001

< 0.001

0.281

0.977

0.427

Change of frailty status#

 Deterioration

73

0.7 ± 7.1

0.7 ± 7.1 c

0.0 ± 1.0

1 (1.4%)

0 (0.0%)

 Unchanged pre-frail or frail

133

0.8 ± 7.5

0.8 ± 7.0 c

0.0 ± 3.6

3 (2.3%)

1 (0.8%)

 Unchanged robustness

223

0.4 ± 9.8 b

0.3 ± 9.6

0.0 ± 2.3

0 (0.0%)

3 (1.4%)

 Improvement

119

0.5 ± 9.6 b

0.5 ± 9.4

0.0 ± 2.6

2 (1.7%)

1 (0.8%)

 p-value+

 

< 0.001

< 0.001

0.197

0.972

0.952

  1. The numbers in bold indicate statistically significant p-values
  2. * Fried et al. proposed the definition of frailty status with the following components: shrinking, weakness, poor endurance and energy, slowness, and low physical activity level
  3. #Changes in frailty status during 1-year period with the following categories: improvement of frailty status, no change between baseline and follow-up, and deterioration for frailty status
  4. +p-values were calculated using univariate negative binomial regression models for the number of outpatient visits, and univariate logistic regression models for the hospitalization and emergency use
  5. a Statistically significant compared with the robust group at baseline using pairwise comparisons with Bonferroni correction (p < 0.05/3 comparisons)
  6. b Statistically significant compared with unchanged unchanged pre-frail or frail group at 1-year follow-up using pairwise comparisons with Bonferroni correction (p < 0.05/6 comparisons)
  7. c Statistically significant compared with unchanged unchanged robustness group at 1-year follow-up using pairwise comparisons with Bonferroni correction (p < 0.05/6 comparisons)